9 Meters Biopharma GAAP EPS of -$0.04 in-line

• 9 Meters Biopharma press release (NASDAQ:NMTR): Q2 GAAP EPS of -$0.04 in-line.
• As of June 30, 2022, the company's cash and cash equivalents totaled approximately $29.5M, compared to approximately $37.2M as of March 31, 2022.